NEW YORK (GenomeWeb) – The US Food and Drug Administration has authorized the use of a PCR-based test for the diagnosis of the Ebola Zaire virus.

The test was developed by the US Department of Defense and uses Thermo Fisher Scientific Life Technologies' TaqMan technology. It is authorized by FDA for use in laboratories "designated by DoD to help facilitate effective responses to the ongoing Ebola outbreak detected in West Africa," a spokesperson for the FDA said in an email to GenomeWeb Daily News.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.

Jul
14
Sponsored by
Agilent Technologies

This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.